Amalgamated Bank’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Buy
29,067
+744
+3% +$40.2K 0.01% 817
2026
Q1
$1.48M Sell
28,323
-917
-3% -$55K 0.01% 931
2025
Q4
$1.72M Sell
29,240
-498
-2% -$30.3K 0.01% 880
2025
Q3
$1.65M Sell
29,738
-562
-2% -$30.1K 0.01% 881
2025
Q2
$1.56M Sell
30,300
-346
-1% -$17.4K 0.01% 881
2025
Q1
$1.8M Buy
30,646
+222
+0.7% +$15K 0.02% 818
2024
Q4
$2.19M Sell
30,424
-454
-1% -$33.3K 0.02% 765
2024
Q3
$2.47M Sell
30,878
-1,067
-3% -$80.2K 0.02% 725
2024
Q2
$2.29M Sell
31,945
-2,396
-7% -$176K 0.02% 793
2024
Q1
$2.42M Sell
34,341
-21,214
-38% -$1.52M 0.02% 786
2023
Q4
$4.29M Sell
55,555
-1,620
-3% -$107K 0.03% 560
2023
Q3
$3.89M Sell
57,175
-941
-2% -$74.3K 0.03% 569
2023
Q2
$4.74M Buy
58,116
+563
+1% +$45.3K 0.04% 459
2023
Q1
$4.27M Sell
57,553
-3,185
-5% -$245K 0.04% 518
2022
Q4
$5.03M Buy
60,738
+1,038
+2% +$82.4K 0.04% 467
2022
Q3
$4.24M Buy
59,700
+212
+0.4% +$18.3K 0.04% 457
2022
Q2
$5.16M Sell
59,488
-2,672
-4% -$250K 0.05% 402
2022
Q1
$6.73M Buy
62,160
+1,132
+2% +$117K 0.05% 331
2021
Q4
$7.89M Buy
61,028
+5,136
+9% +$630K 0.06% 310
2021
Q3
$6.77M Sell
55,892
-68,748
-55% -$8.37M 0.06% 337
2021
Q2
$14M Buy
124,640
+95,464
+327% +$10M 0.11% 143
2021
Q1
$2.79M Sell
29,176
-2,204
-7% -$201K 0.1% 150
2020
Q4
$2.49M Buy
31,380
+116
+0.4% +$8.4K 0.09% 176
2020
Q3
$1.94M Sell
31,264
-828
-3% -$53.9K 0.08% 206
2020
Q2
$2.12M Sell
32,092
-8,884
-22% -$532K 0.1% 168
2020
Q1
$1.94M Sell
40,976
-624
-2% -$31.2K 0.05% 368
2019
Q4
$2.28M Buy
41,600
+2,192
+6% +$115K 0.04% 436
2019
Q3
$1.93M Buy
39,408
+4,824
+14% +$242K 0.04% 455
2019
Q2
$1.8M Sell
34,584
-728
-2% -$36.7K 0.04% 460
2019
Q1
$1.75M Buy
35,312
+488
+1% +$22K 0.04% 460
2018
Q4
$1.26M Buy
34,824
+12,872
+59% +$538K 0.04% 540
2018
Q3
$1.12M Sell
21,952
-14,336
-40% -$635K 0.03% 623
2018
Q2
$1.34M Buy
36,288
+3,168
+10% +$121K 0.03% 596
2018
Q1
$1.25M Buy
33,120
+2,032
+7% +$71.8K 0.03% 594
2017
Q4
$1.01M Buy
31,088
+1,596
+5% +$50.7K 0.03% 711
2017
Q3
$891K Sell
29,492
-188
-0.6% -$5.58K 0.03% 711
2017
Q2
$872K Buy
29,680
+6,016
+25% +$164K 0.03% 729
2017
Q1
$601K Sell
23,664
-4,756
-17% -$123K 0.03% 727
2016
Q4
$731K Buy
28,420
+2,744
+11% +$72.1K 0.03% 642
2016
Q3
$703K Sell
25,676
-16
-0.1% -$439 0.04% 550
2016
Q2
$717K Buy
25,692
+7,604
+42% +$195K 0.04% 544
2016
Q1
$427K Buy
18,088
+1,476
+9% +$32.5K 0.04% 627
2015
Q4
$374K Sell
16,612
-1,156
-7% -$26.4K 0.05% 613
2015
Q3
$411K Buy
17,768
+236
+1% +$5.92K 0.04% 635
2015
Q2
$432K Buy
17,532
+6,788
+63% +$170K 0.04% 676
2015
Q1
$269K Buy
10,744
+580
+6% +$13.8K 0.03% 736
2014
Q4
$235K Buy
10,164
+88
+0.9% +$2.01K 0.04% 727
2014
Q3
$236K Buy
10,076
+184
+2% +$4.31K 0.04% 715
2014
Q2
$229K Sell
9,892
-168
-2% -$3.71K 0.03% 757
2014
Q1
$215K Sell
10,060
-92
-0.9% -$2.07K 0.04% 725
2013
Q4
$240K Buy
+10,152
New +$220K 0.04% 668

Other funds holding TECH

Amalgamated Bank's TECH Position: Q2 2026 in Review

Amalgamated Bank increased its Bio-Techne (TECH) stake by 2.6% in Q2 2026, buying an estimated $40.2K and bringing the position to 29,067 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #817.

Amalgamated Bank first reported a position in TECH in Q4 2013 and has held it in 51 quarters since. The position peaked at $14M in Q2 2021. 287 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Amalgamated Bank held 29,067 shares of Bio-Techne worth $2.05M as of Q2 2026.
  • Amalgamated Bank bought 744 Bio-Techne shares in Q2 2026, an estimated $40.2K.
  • Bio-Techne made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #817 holding.
  • Amalgamated Bank first reported a position in Bio-Techne in Q4 2013 and has held it in 51 quarters since.
  • Amalgamated Bank's Bio-Techne position peaked at $14M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.